421 related articles for article (PubMed ID: 16332591)
1. Number of patients potentially eligible for proton therapy.
Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
[TBL] [Abstract][Full Text] [Related]
2. The potential of proton beam radiation therapy in breast cancer.
Björk-Eriksson T; Glimelius B
Acta Oncol; 2005; 44(8):884-9. PubMed ID: 16332597
[TBL] [Abstract][Full Text] [Related]
3. The potential of proton beam radiation therapy in lung cancer (including mesothelioma).
Bjelkengren G; Glimelius B
Acta Oncol; 2005; 44(8):881-3. PubMed ID: 16332596
[TBL] [Abstract][Full Text] [Related]
4. The potential of proton beam radiation therapy in head and neck cancer.
Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
[TBL] [Abstract][Full Text] [Related]
5. The potential of proton beam radiation therapy in gastrointestinal cancer.
Ask A; Johansson B; Glimelius B
Acta Oncol; 2005; 44(8):896-903. PubMed ID: 16332599
[TBL] [Abstract][Full Text] [Related]
6. The potential of proton beam radiation for palliation and reirradiation.
Björk-Eriksson T; Ask A; Glimelius B
Acta Oncol; 2005; 44(8):918-20. PubMed ID: 16332602
[TBL] [Abstract][Full Text] [Related]
7. The potential of proton beam therapy in paediatric cancer.
Björk-Eriksson T; Glimelius B
Acta Oncol; 2005; 44(8):871-5. PubMed ID: 16332594
[TBL] [Abstract][Full Text] [Related]
8. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.
Björk-Eriksson T; Bjelkengren G; Glimelius B
Acta Oncol; 2005; 44(8):913-7. PubMed ID: 16332601
[TBL] [Abstract][Full Text] [Related]
9. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
Johansson B; Ridderheim M; Glimelius B
Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
[TBL] [Abstract][Full Text] [Related]
10. The potential of proton beam radiation therapy in intracranial and ocular tumours.
Blomquist E; Bjelkengren G; Glimelius B
Acta Oncol; 2005; 44(8):862-70. PubMed ID: 16332593
[TBL] [Abstract][Full Text] [Related]
11. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
12. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
14. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
MacDonald SM; Safai S; Trofimov A; Wolfgang J; Fullerton B; Yeap BY; Bortfeld T; Tarbell NJ; Yock T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):979-86. PubMed ID: 18325681
[TBL] [Abstract][Full Text] [Related]
15. Proton-beam therapy for tumors of the CNS.
Gridley DS; Grover RS; Loredo LN; Wroe AJ; Slater JD
Expert Rev Neurother; 2010 Feb; 10(2):319-30. PubMed ID: 20136386
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
17. Proton beams to replace photon beams in radical dose treatments.
Suit H; Goldberg S; Niemierko A; Trofimov A; Adams J; Paganetti H; Chen GT; Bortfeld T; Rosenthal S; Loeffler J; Delaney T
Acta Oncol; 2003; 42(8):800-8. PubMed ID: 14968940
[TBL] [Abstract][Full Text] [Related]
18. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
Bentzen SM
Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
[No Abstract] [Full Text] [Related]
19. Secondary neutrons in clinical proton radiotherapy: a charged issue.
Brenner DJ; Hall EJ
Radiother Oncol; 2008 Feb; 86(2):165-70. PubMed ID: 18192046
[TBL] [Abstract][Full Text] [Related]
20. The potential role of proton beams in radiation oncology.
Loeffler JS; Smith AR; Suit HD
Semin Oncol; 1997 Dec; 24(6):686-95. PubMed ID: 9422264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
